CCG-222740

CAS No. 1922098-69-8

CCG-222740( —— )

Catalog No. M21055 CAS No. 1922098-69-8

CCG-222740 is an inhibitor of Rho/MRTF pathway.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 53 Get Quote
5MG 88 Get Quote
10MG 152 Get Quote
25MG 286 Get Quote
50MG 441 Get Quote
100MG 653 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CCG-222740
  • Note
    Research use only, not for human use.
  • Brief Description
    CCG-222740 is an inhibitor of Rho/MRTF pathway.
  • Description
    CCG-222740 is an inhibitor of Rho/MRTF pathway.
  • In Vitro
    Cell Cycle Analysis Cell Line:Cancer associated fibroblasts (CAFs) Concentration:10, 20 μM Incubation Time:72 hours Result:Increased the protein levels of p27 and decreased cyclin D1.
  • In Vivo
    Animal Model:KC mice (LSL-KrasG12D/+; Pdx-1-Cre) of age at 9 weeks Dosage:100?mg/kg Administration:Oral gavage; daily; for 7 days Result:Reduced α-SMA levels in the pancreas of caerulein-stimulated KC mice.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Rho
  • Recptor
    Rho
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1922098-69-8
  • Formula Weight
    444.86
  • Molecular Formula
    C23H19ClF2N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL?(280.99 Mm)
  • SMILES
    O=C(Nc1ccc(Cl)cc1)C1CN(C(=O)c2cccc(-c3ccco3)c2)CC(F)(F)C1
  • Chemical Name
    N-(4-chlorophenyl)-55-difluoro-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yu-Wai-Man C Spencer-Dene B Lee R M H et al. Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis[J]. Scientific Reports 2017 7(1):518.
molnova catalog
related products
  • CCG-100602

    CCG-100602 inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC-3 prostate cancer cells (IC50 :9.8 μM).

  • AZA1

    AZA1 (Rac1/Cdc42-IN-1) is a potent dual inhibitor of Rac1 and Cdc42. AZA1 induced apoptosis of prostate cancer cells and inhibited cell proliferation, migration and invasion.

  • CCG-257081

    CCG-257081 (MRTF/SRF-IN-1) is an inhibitor of cardiac myosin-related transcription factor and serum response factor (MRTF/SRF) that acts by inhibiting the Rho/MRTF/SRF pathway.CCG-257081 has shown efficacy in preventing bleomycin-induced fibrosis in several mouse models.